Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback